SCHEMBL17322858

SCHEMBL17322858

COC(=O)C(C)n1nc(-c2ccccc2)c2ccccc21

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.75
▸ MAPT P10636 4/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ KDM4E B2RXH2 5/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ HPGD P15428 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ HSD17B10 Q99714 2/20 0.48
▸ GPR35 Q9HC97 1/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ TSHR P16473 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ F2RL3 Q96RI0 1/20 0.42
▸ RORC P51449 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ PTGER1 P34995 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11835813 0.72 KMT2A (0.73) KMT2AMAPTL3MBTL1KDM4EALDH1A1
SCHEMBL31522420 0.72 CMKLR1 (0.52) KMT2AMAPTL3MBTL1KDM4EALDH1A1
Hydrochloric Acid SCHEMBL11837405 0.71 KMT2A (0.61) KMT2AMAPTL3MBTL1KDM4EALDH1A1
SCHEMBL30885684 0.71 POLB (0.44) KMT2AMAPTL3MBTL1KDM4ESMN1; SMN2
SCHEMBL20562276 0.71 POLB (0.44) KMT2AMAPTL3MBTL1KDM4ESMN1; SMN2
SCHEMBL30912791 0.71 POLB (0.44) KMT2AMAPTL3MBTL1KDM4ESMN1; SMN2
SCHEMBL15631853 0.71 KMT2A (1.00) KMT2AMAPTKDM4EALDH1A1LMNA
SCHEMBL17322842 0.71 SMN1; SMN2 (0.56) KMT2AMAPTKDM4EALDH1A1LMNA
SCHEMBL11837486 0.69 KMT2A (0.58) KMT2AMAPTL3MBTL1KDM4EALDH1A1
SCHEMBL15631864 0.69 KMT2A (0.76) KMT2AMAPTKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 — — US disclosed
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 — — US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 — — US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF CYP11B1, HSP90B1, CYP1B1 KMT2A 4742/4885MAPT 174/4885L3MBTL1 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback